The relationship between surgical treatments and medical treatments in the various
management aspects of the Zollinger-Ellison syndrome (ZES) has taken many forms. In …

Well-differentiated neuroendocrine tumors (NETs) are globally increasing in prevalence and
the liver is the most common site of metastasis. Neuroendocrine liver metastases (NELM) …

Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing transarterial chemoembolisation. It has been …

BACKGROUND: Liver-directed hepatic arterial therapies are associated with improved
survival and effective symptom control for patients with unresectable neuroendocrine liver …

Neuroendocrine tumors (NETs) are an uncommon, heterogeneous group of tumors arising
from cells of neuroendocrine origin, which can be found at multiple sites throughout the …

Abstract Background Lutetium-177-DOTA-octreotate (177 Lu-DOTATATE) significantly
increases survival and response rates in patients with grade I and grade II neuroendocrine …

Interventional radiology plays an important role in the management of patients with
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …

Simple Summary Approximately 80% of metastatic patients with gastroenteropancreatic
neuroendocrine neoplasms (GEP-NENs) have secondary hepatic lesions, and in …

Background: Transarterial chemoembolization (TACE) consists of conventional TACE
(cTACE) and drug-eluting beads TACE (DEB-TACE). The benefits of the 2 treatments remain …

In neuroendocrine neoplasms (NENs), the presence of distant metastases has a severe
impact on survival leading to a relevant decrease in the 5-y survival rate. Here, 90Y …